U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. FDA Study Data Technical Rejection Criteria (TRC): What you need to know! - 05/21/2021
  1. News & Events for Human Drugs

Public | Virtual

Event Title
FDA Study Data Technical Rejection Criteria (TRC): What you need to know!
May 21 - 27, 2021


Date:
May 21 - 27, 2021

 

FDA is planning to implement eCTD validations in 2021 specific to submissions containing study data. FDA published the TRC to assist industry in understanding when a submission containing study will be subject to these study data eCTD validations. This webinar will provide an overview of the TRC and walk through resources currently available to help the sponsor/applicant determine if their submission is subject to these eCTD validations, creation of a simplified TS.XPT, and frequently asked questions.

TOPICS

  • Technical Rejection Criteria (TRC) Background and What’s New
  • Overview of the TRC and Effective Date
  • TRC Warning Metrics
  • CDER SEND Requirements and TRC
  • Preparing a Study Using the Self-Check Worksheet
  • Creating a Simplified TS.XPT File
  • Frequently Asked Questions

FDA PRESENTERS

  • Jiang Xu, Senior Health Informatics Officer, Office of Business Informatics | CDER
  • Lina Cong, Senior Health Informatics Officer, Office of Business Informatics | CDER

ADDITIONAL FDA PANELISTS

  • Jonathan Resnick, Project Management Officer, Office of Business Informatics | CDER
  • Stephanie Leuenroth-Quinn, Associate Director (Acting), Office of New Drugs | CDER
  • Mark Gray, Senior Project Manager, Office of the Director | CBER

INTENDED AUDIENCE

  • Regulatory affairs professionals
  • Consultants working on eCTD submissions containing study data
  • Statisticians and statistical programmers

 FDA RESOURCES

Back to Top